Greenbrook TMS Inc.

Company Description

Greenbrook is a leading provider of Transcranial Magnetic Stimulation, a United States Food and Drug Administration cleared, non-invasive therapy for the treatment of major depressive disorder, and is operating through 41 Company-operated treatment centers,.TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 160,000 TMS treatments to over 4,500 patients struggling with depression.

Address:	890 Yonge Street, 7th Floor Toronto, Ontario, M4W 3P4 Canada
Phone Number:	416 322 9700
Fax Number:
Website:

Industry:	Equip., Software, Syst. & Services
Closing Date:	Wednesday, October 3, 2018
1st Day of Trading:	Wednesday, October 3, 2018
Primary Symbol:	GTMS
Exchange:	Toronto

Proceeds

The net proceeds of the offering will be used for the development of new TMS Centers and related working capital and the repayment of indebtness.

Gross Proceeds:	US $20,000,000.00
Underwrting Fees:	US $707,292.00
Expense Offering:	US $400,000.00
Net Proceeds:	US $18,892,708.00

Lead Underwriter:	Bloom Burton Securities Inc.
Other Underwriter(s):

Performance

	1 day	1 week	1 month	6 months	Inception
Recent Performance	0.00 %	-28.68 %	-62.98 %	-70.34 %	-51.50 %
Post IPO Performance	53.50 %	750.00 %		775.00 %

The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.